EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Alcalosis metabólica en cuidados intensivos

Tomas Rodríguez Yánez, Jorge Rico Fontalvo, Rodrigo Andres Daza Arnedo, Dayro Rodelo Barrios, Carlos Rebolledo M, María Camila Martínez Morales, Elber Luis Osorio Rodríguez, Jhonny Patiño Patiño, Gabriela Lara B, Karina Ramos R, Josser Enrique Jiménez Escobar

Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante · 2025

DOI: 10.56867/115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante, 2025. Verfasst von Tomas Rodríguez Yánez und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In the ICU, metabolic alkalosis is the most common acid-base disorder. A link has been observed between this disorder and an increased risk of death. However, this increased mortality is likely primarily due to the severity of the underlying disease rather than to metabolic alkalosis itself. Objective of the review: This article is a narrative review aimed at updating the diagnosis, treatment, and prognosis of metabolic alkalosis in the context of intensive care management. Key points of the review: Metabolic alkalosis often develops during a hospital stay and is often a consequence of ICU interventions. Mortality in patients with a pH of 7.55-7.56 is 41%, with a pH of 7.57-7.59 it is 47%, with a pH of 7.60-7.64 it is 65%, and with a pH of 7.65-7.70 it is 80%. Hypokalemia is a significant alteration in metabolic alkalosis, causing muscle weakness and paralysis, areflexia, ileus, ST-segment depression, the presence of a U wave, and QT prolongation.

Conclusion

The underlying etiology has a significant influence on mortality associated with metabolic alkalosis. Therapeutic interventions have been limited to guiding adequate fluid management in patients with or without chloride sensitivity; the role of carbonic anhydrase inhibitor-type diuretics has grown, with varying evidence regarding their usefulness.

Zitieren

APA

Yánez, T. R., Fontalvo, J. R., Arnedo, R. A. D., Barrios, D. R., M, C. R., Morales, M. C. M., Rodríguez, E. L. O., Patiño, J. P., B, G. L., R, K. R., & Escobar, J. E. J. (2025). Alcalosis metabólica en cuidados intensivos. Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante. https://doi.org/10.56867/115

Vancouver

Yánez TR, Fontalvo JR, Arnedo RAD, Barrios DR, M CR, Morales MCM, et al. Alcalosis metabólica en cuidados intensivos. Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante. 2025. doi:10.56867/115

BibTeX
@article{Ynez2025,
  author = {Yánez, Tomas Rodríguez and Fontalvo, Jorge Rico and Arnedo, Rodrigo Andres Daza and Barrios, Dayro Rodelo and M, Carlos Rebolledo and Morales, María Camila Martínez and Rodríguez, Elber Luis Osorio and Patiño, Jhonny Patiño and B, Gabriela Lara and R, Karina Ramos and Escobar, Josser Enrique Jiménez},
  title = {Alcalosis metabólica en cuidados intensivos},
  journal = {Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante},
  year = {2025},
  doi = {10.56867/115}
}
Kostenlos starten →